## BACKGROUND. Endocrine therapy for prostate cancer aims to reduce the levels of circulating androgen or to inhibit androgen action by blocking the androgen receptor in the prostate, or both. Studies in various animal and human prostate cancer models suggested that there may be a downregulation o
Expression and function of androgen receptor in carcinoma of the prostate
β Scribed by Zoran Culig; Alfred Hobisch; Georg Bartsch; Helmut Klocker
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 105 KB
- Volume
- 51
- Category
- Article
- ISSN
- 1059-910X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: We investigated modulation of androgen receptor (ar) activity in prostatic tumor cells by luteinizing hormone-releasing hormone (lhrh)-induced increase of the intracellular cyclic adenosine monophosphate (camp) level. ## Methods: Ar transactivation activity was assessed in transien
## BACKGROUND. The predeliction for prostate carcinoma cells to metastasize to bone suggests the hypothesis that bone and/or bone marrow-derived factors may promote prostate carcinoma cell growth or survival, or serve as chemoattractants for these cells. METHODS. We screened three prostate carcino
Androgen receptor (AR) gene amplification was analysed by fluorescence in situ hybridization (FISH) from 24 paraffin-embedded prostate carcinoma samples recurring locally during hormonal therapy and prostate-specific antigen (PSA) expression from 15/24 of these samples was studied by immunohistochem
To shed light on the nature and evolution of structure-function relations in the androgen receptor (AR), we have undertaken a comparative analysis of all available AR and other steroid receptor sequences. We have identified a group of amino acids that "diagnose" the clade of androgen receptors--resi